Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Micron Technology sits at the intersection of memory chips and AI demand. This guide examines whether you should micr...
As market conditions shift in 2026, the math of replacing a $135,000 tech salary without touching principal shows a w...
Rafael Nadal is redefining his legacy, launching a hotel portfolio after amassing a $220 million fortune. He says ret...
Investors ask if Apple stock should be bought before April 30. This guide offers a clear framework, real-world exampl...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...
As 2025 winds down, Coca-Cola and Exxon Mobil stand as twin blue chips with very different stories. One fuels steady ...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Palantir's journey has been a roller coaster—massive gains, sharp pulls, and ongoing questions. This guide distills w...
As tax policy and markets evolve, the math that makes these dividend stocks tax-smart remains a compelling lever for ...
Retirees weighing a $600,000 nest egg are weighing Panama and Portugal for how far the money goes, considering living...